Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
ENDPOINTS NEWS
6m
Viatris, Lexicon ink licensing deal; Capricor’s $75M offering
Plus, news about Kezar Life Sciences and Concentra Biosciences: Viatris, Lexicon Pharmaceuticals sign licensing deal for cardio drug: Per the agreement, Viatris will pay $25 million ...
ENDPOINTS NEWS
47m
Eisai to ask Australia to reconsider rejection of Alzheimer's drug Leqembi
Australia’s regulatory agency rejected Biogen and Eisai’s Alzheimer’s drug Leqembi, noting that the drug's efficacy doesn't ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
One Direction singer dies
Fox News interview
NH justice indicted
Gets minimum 28 years
Exotic cat caught in suburb
100-yr-old capsule unveiled
21K+ SUVs recalled
Synthetic nicotine pouches
Sentenced for cartel bribery
AL voter roll purge blocked
Italy expands surrogacy ban
Disney to debut new pass
To headline Atlanta rally
Cereal dyes protested
New cervical cancer regimen
Abortion group sues Florida
'Click to cancel' finalized
US strikes Houthi targets
Allows EPA emissions rule
To invest in nuclear reactors
MI shooter drill settlement
FDA halts Novavax trial
Had benign cyst removed
Ordered to pay $15 million
GA election rules blocked
To settle US bribery probe
$425M military aid for UKR
Constitution copy auction
SpaceX sues CA regulators
Panel calls for 'reform'
Feedback